McKechnie Duncan
EVP, Chief Commercial Officer · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-02 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 1,541 | $519.00 | $799,779.00 | filing |
| 2026-03-11 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,633 | $498.42 | $1.3M | filing |
| 2026-03-04 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,437 | $475.30 | $1.2M | filing |
| 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,500 | $486.35 | $1.2M | filing |
| 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,410 | $489.00 | $1.2M | filing |
| 2026-02-24 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 873 | $485.11 | $423,501.03 | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,148 | $483.75 | $555,345.00 | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 4,962 | $0.00 | $0.00 | filing |
| 2026-02-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 2,283 | $487.76 | $1.1M | filing |
| 2026-02-10 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,127 | $468.41 | $527,898.07 | filing |
| 2026-01-22 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 4,720 | $0.00 | $0.00 | filing |
| 2026-01-22 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 2,080 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.